BAM
INSP icon

Belpointe Asset Management’s Inspire Medical Systems INSP Stock Holding History

Belpointe Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-104
Closed -$24.3K – 1916
2023
Q1 		$24.3K Buy
104
+25
+32% +$6.32K ﹤0.01% 2194
2022
Q4 		$19.9K Buy
+79
New +$16.8K ﹤0.01% 2190

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Belpointe Asset Management's INSP Position: Q2 2023 in Review

Belpointe Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 104 shares — an estimated $24.3K sold.

Belpointe Asset Management first reported a position in INSP in Q4 2022 and held it in 2 quarters. The position peaked at $24.3K in Q1 2023. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • Belpointe Asset Management reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 104 Inspire Medical Systems shares in Q2 2023, an estimated $24.3K.
  • Belpointe Asset Management first reported a position in Inspire Medical Systems in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Inspire Medical Systems position peaked at $24.3K in Q1 2023.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.